• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于影像学的肌肉和营养不良评估可预测原发性肝细胞癌患者的预后。

Imaging-based assessment of muscles and malnutrition predict prognosis in patients with primary hepatocellular carcinoma.

作者信息

Takada Hitomi, Osawa Leona, Komiyama Yasuyuki, Muraoka Masaru, Suzuki Yuichiro, Sato Mitsuaki, Kobayashi Shoji, Yoshida Takashi, Takano Shinichi, Maekawa Shinya, Enomoto Nobuyuki

机构信息

Gastroenterology and Hepatology Department of Internal Medicine, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan.

出版信息

PLoS One. 2025 Apr 24;20(4):e0307458. doi: 10.1371/journal.pone.0307458. eCollection 2025.

DOI:10.1371/journal.pone.0307458
PMID:40273113
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12021244/
Abstract

BACKGROUND

The significance of imaging-based assessment of muscles and malnutrition in patients with primary hepatocellular carcinoma (HCC) remains unclear. This study aimed to elucidate the prognostic role of the combination of Low Muscle Volume and Value (LMVV) and malnutrition.

METHODS

A total of 714 Child-Pugh grade A/ B patients with first-diagnosed HCC were enrolled, and analyzed factors associated with overall survival. LMVV was defined using psoas muscle mass index and computed tomography values of multifidus muscle at the level of the third lumbar vertebra. We used hypoalbuminemia, Child-Pugh grade B, Subjective Global Assessment (SGA) grade B/C, and Royal Free Hospital Nutrition Prioritizing Tool (RFH-NPT) score > 2 as malnutrition factors in this study.

RESULTS

At baseline, 29% showed LMVV, and 59% met one or more of the malnutrition criteria. No items meeting the criteria of LMVV and malnutrition was observed in 41%, 1 of them was found in 29%, and both were found in 29%. The number of items meeting criteria was an independent factor for a shorter survival. The frequency of liver-related deaths did not differ by presence of LMVV alone, while it was associated with malnutrition. In contrast, the incidence of other types of deaths was influenced by LMVV and malnutrition.

CONCLUSIONS

The combination of LMVV and malnutrition is a prognostic factor in patients with primary HCC.

摘要

背景

基于影像学评估原发性肝细胞癌(HCC)患者的肌肉状况和营养不良的意义仍不明确。本研究旨在阐明低肌肉量值(LMVV)与营养不良联合评估的预后作用。

方法

共纳入714例初诊为HCC的Child-Pugh A/B级患者,分析与总生存期相关的因素。LMVV通过腰大肌质量指数和第三腰椎水平多裂肌的计算机断层扫描值来定义。在本研究中,我们将低白蛋白血症、Child-Pugh B级、主观全面评定法(SGA)B/C级以及皇家自由医院营养优先排序工具(RFH-NPT)评分>2作为营养不良因素。

结果

基线时,29%的患者表现为LMVV,59%的患者符合一项或多项营养不良标准。41%的患者未观察到符合LMVV和营养不良标准的项目,29%的患者有其中一项符合标准,29%的患者两项均符合标准。符合标准的项目数量是生存期较短的独立因素。单纯存在LMVV时,肝相关死亡的发生率无差异,而与营养不良有关。相比之下,其他类型死亡的发生率受LMVV和营养不良的影响。

结论

LMVV与营养不良的联合是原发性HCC患者的一个预后因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22c0/12021244/21c81e5e4943/pone.0307458.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22c0/12021244/1e0cc19e89bb/pone.0307458.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22c0/12021244/8017960c26fd/pone.0307458.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22c0/12021244/fb8c7100c18e/pone.0307458.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22c0/12021244/21c81e5e4943/pone.0307458.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22c0/12021244/1e0cc19e89bb/pone.0307458.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22c0/12021244/8017960c26fd/pone.0307458.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22c0/12021244/fb8c7100c18e/pone.0307458.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22c0/12021244/21c81e5e4943/pone.0307458.g004.jpg

相似文献

1
Imaging-based assessment of muscles and malnutrition predict prognosis in patients with primary hepatocellular carcinoma.基于影像学的肌肉和营养不良评估可预测原发性肝细胞癌患者的预后。
PLoS One. 2025 Apr 24;20(4):e0307458. doi: 10.1371/journal.pone.0307458. eCollection 2025.
2
Reduced muscle mass is an important part of Global Leadership Initiative on Malnutrition criteria in nutritional diagnosis of hepatocellular carcinoma.肌肉减少症是全球营养不足倡议营养不良诊断标准中肝癌营养诊断的重要组成部分。
BMC Gastroenterol. 2024 Oct 10;24(1):358. doi: 10.1186/s12876-024-03438-x.
3
Sarcopenia Impairs Prognosis of Patients with Hepatocellular Carcinoma: The Role of Liver Functional Reserve and Tumor-Related Factors in Loss of Skeletal Muscle Volume.肌肉减少症影响肝细胞癌患者的预后:肝脏功能储备和肿瘤相关因素在骨骼肌量减少中的作用。
Nutrients. 2017 Sep 22;9(10):1054. doi: 10.3390/nu9101054.
4
Association of magnetic resonance imaging-derived sarcopenia with outcomes of patients with hepatocellular carcinoma after hepatectomy.磁共振成像衍生的肌肉减少症与肝癌患者肝切除术后结局的关系。
Abdom Radiol (NY). 2024 Jul;49(7):2272-2284. doi: 10.1007/s00261-024-04439-w. Epub 2024 Jun 20.
5
Clinical importance of muscle volume in lenvatinib treatment for hepatocellular carcinoma: Analysis adjusted with inverse probability weighting.仑伐替尼治疗肝细胞癌中肌肉体积的临床重要性:采用逆概率加权调整的分析。
J Gastroenterol Hepatol. 2021 Jul;36(7):1812-1819. doi: 10.1111/jgh.15336. Epub 2020 Nov 29.
6
Skeletal muscle depletion is an independent prognostic factor for hepatocellular carcinoma.骨骼肌消耗是肝细胞癌的一个独立预后因素。
J Gastroenterol. 2015 Mar;50(3):323-32. doi: 10.1007/s00535-014-0964-9. Epub 2014 May 10.
7
Phase Angle but Not Psoas Muscle Predicts Nutritional Risk and Prognosis in Males with Hepatocellular Carcinoma.相位角而非腰大肌预测肝细胞癌男性的营养风险和预后。
Nutr Cancer. 2024;76(10):963-973. doi: 10.1080/01635581.2024.2378504. Epub 2024 Jul 16.
8
Comparison of Patient-Generated Subjective Global Assessment (PG-SGA) and Mini Nutritional Assessment (MNA) for nutritional assessment in hepatocellular carcinoma patients.患者主观全面评定法(PG-SGA)与微型营养评定法(MNA)在肝细胞癌患者营养评估中的比较
Support Care Cancer. 2025 Jan 21;33(2):116. doi: 10.1007/s00520-025-09176-4.
9
Royal Free Hospital-Nutritional Prioritizing Tool improves the prediction of malnutrition risk outcomes in liver cirrhosis patients compared with Nutritional Risk Screening 2002.皇家自由医院-营养优先工具与营养风险筛查 2002 相比,能更好地预测肝硬化患者的营养不良风险结局。
Br J Nutr. 2020 Dec 28;124(12):1293-1302. doi: 10.1017/S0007114520002366. Epub 2020 Jun 30.
10
Clinical Significance of Biliary Invasion at Diagnosis in Barcelona Clinic Liver Cancer Stage B-C Hepatocellular Carcinoma: A Nationwide Cohort Analysis in South Korea.巴塞罗那临床肝癌分期B-C期肝细胞癌诊断时胆管侵犯的临床意义:韩国一项全国性队列分析
Oncology. 2025;103(4):298-310. doi: 10.1159/000541545. Epub 2024 Sep 19.

本文引用的文献

1
Appraisal of a newly developed ALBI-sarcopenia score as a prognostic marker in patients with hepatocellular carcinoma.评估新开发的 ALBI-肌少症评分作为肝细胞癌患者的预后标志物。
Eur J Gastroenterol Hepatol. 2024 Jul 1;36(7):924-928. doi: 10.1097/MEG.0000000000002776. Epub 2024 Apr 17.
2
Combination of Model for End-Stage Liver Disease (MELD) and Sarcopenia predicts mortality after transjugular intrahepatic portosystemic shunt (TIPS).模型终末期肝病评分(MELD)和肌肉减少症联合预测经颈静脉肝内门体分流术(TIPS)后的死亡率。
Dig Liver Dis. 2024 Sep;56(9):1544-1550. doi: 10.1016/j.dld.2024.03.003. Epub 2024 Mar 29.
3
Branched-chain amino acid supplementation does not improve measures of sarcopenia in cirrhosis: results of a randomised controlled trial.
支链氨基酸补充剂不能改善肝硬化患者的肌肉减少症:一项随机对照试验的结果。
Aliment Pharmacol Ther. 2024 Apr;59(8):941-952. doi: 10.1111/apt.17917. Epub 2024 Feb 26.
4
Assessment of lower limb muscle strength can predict fall risk in patients with chronic liver disease.评估下肢肌肉力量可预测慢性肝病患者的跌倒风险。
Sci Rep. 2024 Jan 2;14(1):64. doi: 10.1038/s41598-023-50574-7.
5
Impact of sarcopenia and sarcopenic obesity on survival in patients with primary liver cancer: a systematic review and meta-analysis.肌肉减少症和肌肉减少性肥胖对原发性肝癌患者生存的影响:一项系统评价和荟萃分析。
Front Nutr. 2023 Oct 19;10:1233973. doi: 10.3389/fnut.2023.1233973. eCollection 2023.
6
Meld-sarcopenia score and skeletal muscle density predicts short-term readmission of patients with hepatic encephalopathy.MELD-sarcopenia 评分和骨骼肌密度预测肝性脑病患者的短期再入院。
Eur J Radiol. 2023 Dec;169:111178. doi: 10.1016/j.ejrad.2023.111178. Epub 2023 Oct 31.
7
Branched-chain amino acids supplementation improves liver frailty index in frail compensated cirrhotic patients: a randomized controlled trial.支链氨基酸补充可改善虚弱代偿性肝硬化患者的肝脆弱指数:一项随机对照试验。
BMC Gastroenterol. 2023 May 15;23(1):154. doi: 10.1186/s12876-023-02789-1.
8
Albumin-Globulin Score Combined with Skeletal Muscle Index as a Novel Prognostic Marker for Hepatocellular Carcinoma Patients Undergoing Liver Transplantation.白蛋白-球蛋白评分联合骨骼肌指数作为肝移植肝细胞癌患者的新型预后标志物
J Clin Med. 2023 Mar 14;12(6):2237. doi: 10.3390/jcm12062237.
9
Body composition as a predictor of chemotherapy-related toxicity in ovarian cancer patients: A systematic review.身体成分作为卵巢癌患者化疗相关毒性的预测指标:一项系统综述。
Front Oncol. 2022 Nov 2;12:1057631. doi: 10.3389/fonc.2022.1057631. eCollection 2022.
10
The combination of sarcopenia and biochemical factors can predict the survival of hepatocellular carcinoma patients receiving transarterial chemoembolization.肌肉减少症与生化因素的结合可预测接受经动脉化疗栓塞的肝细胞癌患者的生存期。
Front Oncol. 2022 Sep 29;12:1005571. doi: 10.3389/fonc.2022.1005571. eCollection 2022.